ArticleAnnals of internal medicine2023
In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y.
Y Diana Kwong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
ArticleAnnals of internal medicine2023
Y Diana Kwong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.